Expression and antigenicity of Plasmodium falciparum major merozoite surface protein (MSP119) variants secreted from Saccharomyces cerevisiae

This publication has 16 references indexed in Scilit:

• Monoclonal antibodies that inhibit Plasmodium falciparum invasion in vitro recognise the first growth factor-like domain of merozoite surface protein-1
  Molecular and Biochemical Parasitology, 1993
• Sequence conservation in the C-terminal part of the precursor to the major merozoite surface proteins (MSP1) ofPlasmodium falciparum from field isolates
  Molecular and Biochemical Parasitology, 1993
• Analysis of sequence diversity in the Plasmodium falciparum merozoite surface protein-1 (MSP-1)
  Molecular and Biochemical Parasitology, 1993
• Mapping of the region predominantly recognized by antibodies to the Plasmodium falciparum merozoite surface antigen MSA 1
  Molecular and Biochemical Parasitology, 1992
• A malaria merozoite surface protein (MSP1)-structure, processing and function
  Memórias do Instituto Oswaldo Cruz, 1992
• Recombinant Pfs25 protein of Plasmodium falciparum elicits malaria transmission-blocking immunity in experimental animals.
  The Journal of Experimental Medicine, 1991
• Proteolytic processing of thePlasmodium falciparum merozoite surface protein-1 produces a membrane-bound fragment containing two epidermal growth factor-like domains
  Molecular and Biochemical Parasitology, 1991
• A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies.
  The Journal of Experimental Medicine, 1990
• A vaccine candidate from the sexual stage of human malaria that contains EGF-like domains
  Nature, 1988
• The three major antigens on the surface of Plasmodium falciparum merozoites are derived from a single high molecular weight precursor.
  The Journal of Experimental Medicine, 1984